Pagina 3 - U.S. Groei aandelen Pharmaceuticals & Biotech

UPDATED Mar 16, 2026

Ontdek U.S. Pharmaceuticals & Biotech Groeiaandelen die op de NYSE en NASDAQ staan. Gesorteerd op voorspelde groei, hebben deze Pharmaceuticals & Biotech Stocks een hoger dan verwachte winst- of omzetgroei in vergelijking met andere bedrijven.

713 bedrijven
BedrijfLaatste prijs7D Terugkeer1 J RendementMarktkapitalisatieDoel analistenWaarderingGroeiDiv Opbrengst
INDP
US$1.75-6.4%-92.3%US$3.9mUS$10.000.963.3%n/a
IBRX
US$8.21-2.8%182.1%US$8.6bUS$14.8074.563.3%n/a
INSM
US$144.601.0%85.9%US$30.1bUS$213.0051.463.2%n/a
RYTM
US$90.51-2.7%72.9%US$6.0bUS$140.6732.663.0%n/a
GERN
US$1.651.9%-5.2%US$1.0bUS$3.405.762.5%n/a
MRKR
US$1.41-4.1%10.2%US$22.2mUS$7.875.062.4%n/a
CLNN
US$5.968.5%30.6%US$67.4mUS$30.33350.762.4%n/a
CAPR
US$30.56-0.2%137.3%US$1.7bUS$53.7020.962.0%n/a
SVRA
US$5.23-3.7%86.1%US$1.3bUS$10.816.562.0%n/a
ADCT
US$4.22-0.2%135.8%US$524.7mUS$8.006.661.3%n/a
BBIO
US$71.038.2%115.2%US$13.5bUS$99.9627.461.2%n/a
RLYB
US$9.41-12.6%83.2%US$50.3mn/a73.961.2%n/a
KPRX
US$2.09-2.3%-36.5%US$7.7mUS$12.000.361.1%n/a
COGT
US$35.68-3.6%382.8%US$5.5bUS$54.1710.561.1%n/a
SCLX
US$8.43-1.7%-19.7%US$50.7mn/a1.361.0%n/a
NAMS
US$29.79-3.2%27.6%US$3.3bUS$48.02152.260.9%n/a
OMER
US$11.14-1.3%30.8%US$793.4mUS$38.00-6.560.9%n/a
CMPX
US$5.41-0.2%130.2%US$934.7mUS$13.645.060.8%n/a
ARTL
US$4.1518.2%-75.8%US$2.7mn/a-0.260.7%n/a
PRLD
US$3.368.7%345.1%US$272.4mUS$5.1722.860.6%n/a
AVXL
US$4.71-1.7%-48.8%US$430.9mUS$22.003.460.6%n/a
ITRM
US$0.17-4.4%-87.8%US$9.1mUS$9.0023.260.6%n/a
CRSP
US$48.42-17.6%13.1%US$4.7bUS$83.741324.160.6%n/a
CLGN
US$0.61-3.2%-80.8%US$8.4mUS$11.123.560.5%n/a
Page 3 of 30